Literature DB >> 1279369

Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes.

I Sominskaya1, P Pushko, D Dreilina, T Kozlovskaya, P Pumpen.   

Abstract

The minimal amino acid sequence sufficient to be recognized efficiently by virus-attachment inhibiting murine monoclonal anti-preS1 antibody MA18/7 has been determined. We have constructed a recombinant gene library using the cloned coat protein gene of Escherichia coli RNA bacteriophage fr as a carrier. Different fragments of preS1 region from cloned hepatitis B virus (HBV) genomes, subtype ayw and adw, were inserted at position 2 of the 129 amino acid-long fr coat protein gene in the appropriate E. coli expression vectors. Fine mapping of preS1 epitope recognized by MA18/7 was accomplished by bidirectional shortening of the preS1 within original recombinant preS-fr coat protein genes with Bal31 exonuclease. Immunoblot analysis of the obtained recombinant protein library revealed that the tetrapeptide Asp-Pro-Ala-Phe (DPAF), located at the position preS(31-34) and conserved in all known HBV genomes, is sufficient to bind MA18/7 antibody. Recognition of the preS1 region by MA18/7 occurred irrespective of the amino acid context surrounding this DPAF tetrapeptide. Further shortening of this minimal epitope from the left or from the right side completely prevented antibody binding in immunoblots.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279369     DOI: 10.1007/BF00215767

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  30 in total

1.  A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.

Authors:  D R Milich; A McLachlan; A Moriarty; G B Thornton
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

2.  Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus.

Authors:  J Salfeld; E Pfaff; M Noah; H Schaller
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Variable protein composition of hepatitis B surface antigen from different donors.

Authors:  W Stibbe; W H Gerlich
Journal:  Virology       Date:  1982-12       Impact factor: 3.616

5.  Structural relationships between minor and major proteins of hepatitis B surface antigen.

Authors:  W Stibbe; W H Gerlich
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

6.  Ribonucleoprotein complexes formed between bacteriophage MS2 RNA and MS2 protein in vitro.

Authors:  T Sugiyama; R R Hebert; K A Hartman
Journal:  J Mol Biol       Date:  1967-05-14       Impact factor: 5.469

7.  Hepatitis B virus contains pre-S gene-encoded domains.

Authors:  A R Neurath; S B Kent; N Strick; P Taylor; C E Stevens
Journal:  Nature       Date:  1985 May 9-15       Impact factor: 49.962

8.  Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.

Authors:  L T Mimms; M Floreani; J Tyner; E Whitters; R Rosenlof; L Wray; A Goetze; V Sarin; K Eble
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

9.  Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus.

Authors:  A R Neurath; S B Kent; N Strick; K Parker
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

10.  Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region.

Authors:  P Pontisso; M A Petit; M J Bankowski; M E Peeples
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

View more
  13 in total

Review 1.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.

Authors:  S Ren; M Nassal
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  HBV infection of cell culture: evidence for multivalent and cooperative attachment.

Authors:  N Paran; B Geiger; Y Shaul
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

4.  Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.

Authors:  Irina Sominskaya; Dace Skrastina; Andris Dislers; Denis Vasiljev; Marija Mihailova; Velta Ose; Dzidra Dreilina; Paul Pumpens
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

5.  Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus.

Authors:  Seung-Wook Chi; Do-Hyoung Kim; Si-Hyung Lee; Iksoo Chang; Kyou-Hoon Han
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

6.  Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1.

Authors:  M Seifer; D N Standring
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Authors:  Dieter Glebe; Mehriar Aliakbari; Peter Krass; Eva V Knoop; Klaus P Valerius; Wolfram H Gerlich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.

Authors:  Xiaohui Li; Peter Pushko; Irina Tretyakova
Journal:  J Vaccines Vaccin       Date:  2015-06-30

9.  Structures of hepatitis B virus cores presenting a model epitope and their complexes with antibodies.

Authors:  A M Roseman; O Borschukova; J A Berriman; S A Wynne; P Pumpens; R A Crowther
Journal:  J Mol Biol       Date:  2012-06-28       Impact factor: 5.469

10.  Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein.

Authors:  V Bruss; X Lu; R Thomssen; W H Gerlich
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.